Enanta Pharmaceuticals Inc. (ENTA): Earnings per share for the last twelve months

Corporate company logo of Enanta Pharmaceuticals (ENTA)

Enanta Pharmaceuticals focuses on developing innovative small-molecule therapeutics against hepatitis B and RSV. Strict FDA oversight and patent protection ensure a high barrier to entry. The company's revenues are based on royalty payments from major partners. The company's annual net profit per share confirms its financial stability, with the value stabilizing at -2.42.

Enanta Pharmaceuticals (ENTA) - Net earnings per share (EPS TTM) from 07/04/2022 to 11/16/2026

Analytical breakdowns and data insights for company Enanta Pharmaceuticals, Inc (ENTA)

Fundamental valuation:enanta.com (ENTA)
Manufactured products of Enanta

Diversification of developments against viral infections and stable royalties from partners minimize R&D risks for Enanta Pharmaceuticals (ENTA), ensuring a resilient financial foundation. The net income per share value over the last 12 months reflects the actual earnings per share, stripped of speculative noise, allowing investors to timely identify business growth points or the risk of missed opportunities through an analysis of the chart's price action.

Competitors of Enanta Pharmaceuticals (ENTA)

Gilead - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Cidara Corp CDTX|Novavax Corp (NVAX) - Earnings per share for the last twelve months|CureVac N.V. - Earnings per share for the trailing year|Net earnings per share for the last 12 months VALN|Vir Biotechnology (VIR) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months SIGA Technologies Inc (SIGA)|EBS - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) AVIR (Atea Pharma)|Net earnings per share for the last four quarters Invivyd, Inc. (IVVD)|INO - Earnings per share for the last twelve months|Net earnings per share for the last four quarters hillevax.com HLVX|Kalaris Therapeutics (KLRS) - Earnings per share for the last twelve months|Dyadic International Inc (DYAI) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months NanoViricides Inc.|Talphera Corp - Earnings per one share for the last 12 months|Net earnings per share for the last 12 months COCP (Cocrystal Pharma Inc)|Net earnings per share for the last four quarters Traws Therapeutics|Earnings per share for the last twelve months Dogwood Therapeutics DWTX|Net earnings per share for the trailing year Qualigen Therapeutics, Inc.|ALVR - Earnings per share for the last twelve months|vbivaccines.com (VBIV) - Net earnings per share for the last 12 months|VIRI (virios.com) - Net earnings per share for the last 12 months|VXRT - Net earnings per share for the last four quarters